Scarica l'app Stockscreener
1.47
2.08%
0.03
Pre-mercato:
1.49
0.02
+1.36%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GERN Giù?
Forum
Previsione
Geron Corp Borsa (GERN) Ultime notizie
Geron Corporation $GERN Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Soleus files 5.2% stake in Geron (GERN) via master fund - Stock Titan
Is Geron (GERN) Using Its New ATM Program To Prioritize Flexibility Over Shareholder Dilution? - Yahoo Finance
Geron at TD Cowen: Strategic Growth and Market Expansion - Investing.com
Geron (NASDAQ: GERN) launches $150M ATM sales agreement with TD Cowen - Stock Titan
Geron 10-K: Revenue $183.9M, EPS (0.13) - TradingView
HC Wainwright Issues Optimistic Outlook for Geron Earnings - MarketBeat
Geron (GERN) 2025 Revenue Surges to $183.6M Driven by RYTELO Commercial Success - Yahoo Finance
Geron Corporation (NASDAQ:GERN) Q4 2025 Earnings Call Transcript - Insider Monkey
Geron (GERN) Pops on FDA Nod: Is This Small-Cap Biotech Now Underpriced? - AD HOC NEWS
Geron shares drop after Q4 results miss estimates despite Rytelo growth - MSN
Geron Corp (GERN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments - Investing.com Canada
Geron Corp (GERN) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
Geron (GERN) Projects Strong Revenue and Manages Expenses for 20 - GuruFocus
Why Geron (GERN) Is Up 8.3% After Narrowing Losses And Boosting 2026 RYTELO Outlook - simplywall.st
Geron Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Geron (NASDAQ:GERN) Releases Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Why Did GERN Stock Tumble 10% Pre-Market Today? - Stocktwits
Geron Q4 Earnings Call Highlights - MarketBeat
Geron Corporation (GERN) Shares Plummet After Missing Q4 2025 Ex - GuruFocus
Earnings call transcript: Geron Q4 2025 results miss forecasts, stock plunges - Investing.com
Geron (GERN) Targets RYTELO Growth with Strategic Actions in 202 - GuruFocus
Geron: Overview of Fourth Quarter Financial Results - Bitget
Geron earnings missed by $0.02, revenue fell short of estimates - Investing.com
GERON ($GERN) Releases Q4 2025 Earnings - Quiver Quantitative
Geron: Q4 Earnings Snapshot - Barchart.com
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - TradingView
RYTELO drives Geron (GERN) 2025 revenue surge and 2026 guidance - Stock Titan
Geron Corporation Reports $184 Million in RYTELO® Revenue for 2025 and Provides 2026 Financial Guidance - Quiver Quantitative
Earnings Summary: Geron Q4 - Benzinga
Cancer drug RYTELO brings in $184M as Geron cuts a third of staff - Stock Titan
Geron Corporation (NASDAQ:GERN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Assessing Geron (GERN) Valuation After Recent Short Term Share Price Momentum - Yahoo Finance
Geron Corp. Stock Hits Day Low of $1.72 Amid Price Pressure - Markets Mojo
Geron (GERN) Set to Announce Q4 Earnings - GuruFocus
Geron (NASDAQ:GERN) Stock Price Up 8.8%Still a Buy? - MarketBeat
Geron Corporation Q4 Financial Announcement Sparks Investor Curiosity - StocksToTrade
Is Geron (GERN) Pricing Look Attractive After Recent Share Price Rebound? - Yahoo Finance
Geron earnings up next: Can RYTELO sustain revenue momentum? By Investing.com - Investing.com South Africa
Geron earnings up next: Can RYTELO sustain revenue momentum? - Investing.com
Geron (GERN) Sets 2026 Financial Goals, TD Cowen Cuts PT - Insider Monkey
Geron Plans to Present at Upcoming Investor Conferences - The Manila Times
Geron Corporation Management to Present at Upcoming Investor Conferences in March 2026 - Quiver Quantitative
Biotech Geron lines up March investor talks in Boston and Miami - Stock Titan
Does Geron Corporation offer margin of safetyQuarterly Portfolio Review & AI Optimized Trading Strategy Guides - mfd.ru
Geron (NASDAQ:GERN) Trading Down 6%Here's Why - MarketBeat
Geron Corporation (GERN) Stock Analysis: An Insight into the Biotech Player’s 77% Potential Upside - DirectorsTalk Interviews
Top 2 Industrials Stocks That Are Ticking Portfolio Bombs - Benzinga
Gains Report: Will Geron Corporation benefit from geopolitical trendsGold Moves & Fast Moving Trade Plans - baoquankhu1.vn
Geron (GERN) CFO granted 1.66M options and sells shares for taxes - Stock Titan
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
MSN Money - MSN
Top 3 Health Care Stocks That May Collapse This Quarter - Benzinga
Geron (GERN) to Release Quarterly Earnings on Wednesday - MarketBeat
Geron (NASDAQ:GERN) Trading Up 7.3%Time to Buy? - MarketBeat
Geron Corporation Reveals 2025 Full Year Financials Amidst Changing Analyst Opinions - StocksToTrade
Should I set a stop loss on Geron CorporationMarket Trend Review & Weekly Top Gainers Trade List - mfd.ru
Geron Corporation (NASDAQ:GERN) Sees Significant Decline in Short Interest - MarketBeat
Can Geron Corporation deliver consistent dividendsJuly 2025 Chart Watch & Expert Approved Trade Ideas - mfd.ru
GERN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
GERNW SEC FilingsGeron Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Geron Corporation (GERN) Stock Analysis: A Potential 108% Upside Opportunity In Biotechnology - DirectorsTalk Interviews
0.11%
6.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):